Clear cell (cc) RCC commonly involves mutations in the tumor suppressor Von Hippel–Lindau gene, triggering a decrease in the degradation of hypoxia-inducible factor and an increase in VEGF transcription, which leads to tumor angiogenesis [9]. The gene discussed is VEGFA; the disease is neoplasm.